What Are the Implications for Pharmacology and Toxicology?
Gray baby syndrome underscores the importance of understanding pharmacokinetics and pharmacodynamics in different populations. It highlights the need for developing age-appropriate dosing regimens and the consideration of pharmacogenomics in clinical settings. The syndrome also serves as a cautionary tale about the risks of drug therapy in vulnerable populations and the need for ongoing research into safer therapeutic agents.
